leisure time -WSS

leisure time

author：leisure time 2025-09-27 09:46:21 - browse：2

Richard Neal. -- health policy coverage from STAT — Rep. Richard Neal (D-Mass.) Drew Angerer/Getty Images

WASHINGTON — A rift between Democrats and Republicans over health care transparency was on full display in the House on Wednesday.

Republicans on the House Ways & Means Committee introduced a package this week that they say would increase health care transparency, but Democrats and outside groups are arguing that it doesn’t go far enough to force companies to disclose information about their ownership. They also think it goes too easy on the private equity firms that are buying up health care practices.

“There was an opportunity here for bipartisanship, but I think we ought to reference that in the past tense,” said ranking Democrat Richard Neal (D-Mass.).

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Readout Newsletter: CAR

WSS

Why scientists need input from humanists on sensitive research

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

Positive childhood experiences can help future health

Positive childhood experiences can help future health

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

App could help diagnose ear infections more accurately — and at home

hotspot

leisure time

hotspot

Heart attack and stroke risk calculators need revising

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

Heart attack and stroke risk calculators need revising

Ebola: Gilead Sciences antiviral shows promise as new treatment

Walensky prepares to leave CDC — and Congress — behind

Health AI adoption puts security, privacy startups on investors' radar

Guidelines to prevent youth baseball injuries need more muscle

Nurses recount patients attacks

Sports medicine is finally prioritizing gender equality

President Biden's budget: Here's what you might have missed

hotspot

Gene editing the human germline: What are the risks?

Pushing for an NIH office for post

Male and female sex labels in research insufficient, scientists say

CVS Caremark has created a new ploy: the drug ‘rebate credit’

Virtual Event: March of the Biosimilars

Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

entertainment

focus

focus

hotspot